Abstract Body

The viral envelope glycoprotein complex (Env) is essential in the first stage of HIV infection life cycle and its function has been associated to HIV pathogenesis. Therefore, we explored the relationship between the Env functions and the long-term viral load control in HIV-infected individuals.

We genotypically and phenotypically characterized 41 Envs from 29 patients with different clinical progression rates. 10 Envs isolated from 7 Long Term Non Progressors-Elite Controllers (LTNP-EC) individuals with undetectable VL for >20 years and infected in the 90’s; 10 Env clones isolated from 6 viremic LTNPs with detectable VL<10,000/copies/mL also infected in the 90's. As reference, we analyzed 10 Envs obtained from 6 HIV-1 individuals infected in the 90's, but with high VL>10^5 and a normal chronic infection (Ancient-P) and 11 viral clones from 10 HIV-1 individuals infected between 2013-2014 and with similar VL (Modern-P). We analyzed cell-surface expression levels by flow cytometry; fusogenicity in cell-to-cell fusion assays; CD4 affinity in a viral transfer capacity, which exclusively depends on the binding of gp120 to the CD4 receptor; and infectivity of cell-free viruses in TZM-bl cells.

We did not observe statistically significant differences in cell-surface expression among the four different Env groups. However, a statistically significant lower fusogenicity, CD4 binding and infectivity was observed in Env isolated from LTNP compared to Ancient-P and Modern-P (p<0.05 in all cases). NO differences in these parameters were observed between EC and viremic LTNPs. Genotypic analysis showed differences in the length and glycosylation sites of Env, mainly impacting the V5 loop that showed shorter length in both groups pf LTNPs. Lower differences were observed in V1-V2 and V4 loops, while V3 loop remained constant among groups. In general, we observed that shorter and less glycosylated Env had lower expression, fusion and transfer capacity.

Our data suggest that there is a link between critical Env-associated viral functions and the clinical progression of the studied individuals. Our data support the hypothesis that poorly functional viral Envs could be critical for the control of viral replication and HIV pathogenesis. These viral characteristics represent potential new anti-HIV biomarkers for the development of innovative therapeutic strategies.